The Uniject device with a short needle for subcutaneous contraceptive injection.
Injectable contraceptives in the Uniject® device
Injectable contraceptives such as Depo-Provera® are increasingly popular with women around the globe. One injection every three months provides a safe, effective, reversible, and discreet method to prevent pregnancy. Many women, however, cannot routinely get to clinics that offer this form of contraception, while others start using the method but stop because they cannot return to the clinic.
Depo-subQ provera 104™, a new subcutaneous formulation that will soon be available in the Uniject device, promises to help improve women’s access to injectable contraceptives. Read more about this exciting development in the field of family planning.
Uniject is a registered trademark of BD. Depo-Provera and depo-subQ provera 104 are trademarks of Pfizer.
Photo: PATH/Patrick McKern.